CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
Clinical trial NCT02013817 · COMPLETED
Trial details
- NCT number
- NCT02013817
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-11
- Primary completion
- 2012-09-24
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.